Drugs / Uric Acid
Uric Acid
also known as
2,6,8-trioxypurine · Idelalisib metabolite m54 · Lithic acid · NSC-3975 · Uricum acidum
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01323335 | Mar 2009 → Jan 2014 | — | National Institute on Aging (NIA) | Completed | No outcome recorded |
| Phase 2/31 trial · 1 missed | ||||||
| Phase 2/3 | NCT00860366 | Jun 2011 → Aug 2013 | ischemic stroke | Angel Chamorro, MD | Completed | Missed primary |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Uric Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00860366 ↗ |
| Known as | 2,6,8-trioxypurine | ChEMBL registry synonym — accepted as the source's own label CHEMBL792 ↗ |
| Known as | Idelalisib metabolite m54 | ChEMBL registry synonym — accepted as the source's own label CHEMBL792 ↗ |
| Known as | Lithic acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL792 ↗ |
| Known as | NSC-3975 | ChEMBL registry synonym — accepted as the source's own label CHEMBL792 ↗ |
| Known as | Uricum acidum | ChEMBL registry synonym — accepted as the source's own label CHEMBL792 ↗ |
| Modality | Small molecule | — CHEMBL792 ↗ |
| Route | Intravenous | “Single intravenous infusion” NCT00860366 ↗ |